 |
|
|
|
|
 |
Last Updated: Jan 23, 2010 - 6:09:50 AM |
Latest Research
:
Infectious Diseases
:
Influenza
Influenza predisposes to secondary bacterial infections
Current research suggests that the flu may predispose to secondary bacterial infections, which account for a significant proportion of mortality during flu pandemics. The related report by Lee et al, "A mouse model of lethal synergism between influenza virus and Haemophilus influenzae," appears in the February 2010 issue of The American Journal of Pathology.
Jan 23, 2010 - 6:03:22 AM
|
Latest Research
:
Infectious Diseases
Helicobacter pylori may enhance immunity against tuberculosis
It’s been implicated as the bacterium that causes ulcers and the majority of stomach cancers, but studies by researchers at UC Davis, Stanford University and the University of Pittsburgh have found that Helicobacter pylori (H. pylori) also may play a protective role, against the worldwide killer, tuberculosis (TB).
Jan 23, 2010 - 4:10:52 AM
|
Latest Research
:
Infectious Diseases
:
HCV
Caffeine intake in chronic hepatitis C patients associated with less liver fibrosis
Researchers from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) determined that patients with chronic hepatitis C virus (HCV) who consumed more than 308 mg of caffeine daily had milder liver fibrosis.
Jan 5, 2010 - 1:41:15 PM
|
Latest Research
:
Infectious Diseases
Study into Rev protein which helps in the spread of the virus
Professor Denis Archambault of the Department of Biological Sciences of Université du Québec à Montréal (UQAM), and doctoral student Andrea Corredor Gomez have made a major discovery in the field of molecular biology. They have unlocked some of the secrets of a viral protein, known as Rev, which is very different from other proteins of the same type studied to date. The results of their research were recently published in the prestigious Journal of Virology.
Jan 5, 2010 - 1:22:22 PM
|
Latest Research
:
Infectious Diseases
:
Influenza
Closing schools for short periods does not decrease infection rates
Closing schools for less than two weeks during a flu pandemic may increase infection rates and prolong an epidemic, say University of Pittsburgh researchers in a study published ahead-of-print and online in the Journal of Public Health Management and Practice.
Dec 30, 2009 - 12:43:05 PM
|
Latest Research
Think again about keeping little ones so squeaky clean
EVANSTON, Ill. --- A new Northwestern University study suggests that American parents should ease up on antibacterial soap and perhaps allow their little ones a romp or two in the mud --- or at least a much better acquaintance with everyday germs.
Dec 8, 2009 - 4:59:36 AM
|
Latest Research
HIV-related memory loss linked to Alzheimer's protein
More than half of HIV patients experience memory problems and other cognitive impairments as they age, and doctors know little about the underlying causes. New research from Washington University School of Medicine in St. Louis suggests HIV-related cognitive deficits share a common link with Alzheimer's-related dementia: low levels of the protein amyloid beta in the spinal fluid.
Dec 7, 2009 - 4:59:36 AM
|
Latest Research
No-entry zones for AIDS virus
The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs.
Nov 12, 2009 - 4:59:36 AM
|
Latest Research
Indiana U. at APHA: Studies about why men and women use lubricants during sex
An Indiana University study involving 2,453 women ages 18 to 68 found that lubricant use during sexual activity alone or with a partner contributed to higher ratings of pleasurable and satisfying sex.
Nov 9, 2009 - 4:59:36 AM
|
Latest Research
Federal stimulus funds support studies geared to improving HIV care and prevention
UCSF HIV researchers have received two NIH grants of $1 million each to study the use of web-based, patient controlled personal health records to improve health and HIV prevention outcomes for HIV positive patients.
Nov 5, 2009 - 4:59:36 AM
|
Latest Research
Specialists in hearing, HIV come together to study AIDS patients
Specialists in HIV and in hearing at the University of Rochester Medical Center are teaming up to measure the hearing of people with AIDS.
Nov 3, 2009 - 4:59:36 AM
|
Latest Research
NIH launches 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women
The first clinical trials to test whether the 2009 H1N1 influenza vaccine can safely elicit a protective immune response in pregnant women launched yesterday, and a trial to conduct the same test in HIV-infected children and youth will begin next week. The International Maternal Pediatric Adolescent AIDS Clinical Trials Group is conducting the studies, which are sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), both part of the National Institutes of Health.
Oct 9, 2009 - 3:59:36 AM
|
Latest Research
HIV vaccine regimen demonstrates modest preventive effect in Thailand clinical study
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced today that the prime-boost investigational vaccine regimen was safe and 31 percent effective in preventing HIV infection.
Sep 24, 2009 - 3:59:36 AM
|
Latest Research
Clinical trial of antiretroviral-based HIV prevention strategies for women now under way
A new, large-scale clinical trial is examining whether antiretroviral medications normally used to treat HIV infection can also prevent HIV infection in women when applied as a vaginal gel or taken as oral tablets once daily.
Sep 16, 2009 - 3:59:36 AM
|
Latest Research
:
Infectious Diseases
:
Influenza
:
H1N1
Clinical trials of 2009 H1N1 influenza vaccines
Reports are now emerging from various clinical trials of 2009 H1N1 influenza vaccines, conducted by various vaccine manufacturers. The early data from these trials indicate that 2009 H1N1 influenza vaccines are well tolerated and induce a strong immune response in most healthy adults when administered in a single unadjuvanted 15-microgram dose.
Sep 13, 2009 - 1:37:45 PM
|
Latest Research
ART therapy for babies, mothers safely reduces HIV transmission
Giving daily antiretroviral syrup to breastfeeding infants or treating their HIV-infected mothers with highly active antiretroviral drugs is safe and effective in preventing mother-to-child HIV transmission through breast milk, a study led by University of North Carolina at Chapel Hill investigators has found.
Jul 22, 2009 - 3:59:36 AM
|
Latest Research
New method for HIV testing holds promise for developing world
DURHAM, NC -- A new technique that detects the HIV virus early and monitors its development without requiring refrigeration may make AIDS testing more accessible in sub-Saharan Africa.
Jul 21, 2009 - 3:59:36 AM
|
Latest Research
:
Infectious Diseases
:
AIDS
Treatment with highly active antiretroviral therapy for HIV helps control Hepatitis B
Prolonged use of highly active antiretroviral therapy (HAART) to treat people infected with both HIV and hepatitis B (HBV) helps to better control the hepatitis B infection and could delay or prevent liver complications, according to a new study by researchers at Wake Forest University School of Medicine.
Jul 15, 2009 - 2:12:13 PM
|
Latest Research
:
Infectious Diseases
Condom use reduces risk of contracting herpes simplex virus 2
Condom use is associated with a reduced risk of contracting herpes simplex virus 2, according to a report based on pooled analysis of data from previous studies in the July 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Jul 13, 2009 - 3:40:05 PM
|
Latest Research
Probiotics can increase effectiveness of some antibiotic therapies
Antimicrobial treatments for bacterial vaginosis (BV) are effective, but taking lactobacillus tablets alongside metronidazole antibiotic therapy increases effectiveness over taking this antibiotic alone, according to a Cochrane Systematic Review. The researchers also concluded that intravaginal lactobacillus was as effective as oral metronidazole, although they did note unexplained drop-outs from the trials.
Jul 9, 2009 - 3:59:36 AM
|
Medical News
:
Professionals
:
Doctors
Indian American helps design vaginal ring to prevent HIV transmission
An Indian American endocrinologist has helped develop a vaginal ring that would prevent conception and transmission of HIV infection, by releasing multiple types of non-hormonal agents and microbicides.
Jun 18, 2009 - 12:27:35 PM
|
Latest Research
:
Infectious Diseases
:
Dengue
Tiny fly can keep dengue-causing mosquito in check
The larvae of a tiny fly or midge can help decimate a number of invasive Asian tiger mosquitoes, that infect 50 to 100 million people with dengue fever every year in the tropics.
Jun 9, 2009 - 1:35:24 PM
|
Latest Research
:
Infectious Diseases
:
Influenza
:
H1N1
Analysis of a critical protein produced by the 2009 H1N1 influenza A virus
In just two weeks from the time the first patient virus samples were made available, Singapore scientists report an evolutionary analysis of a critical protein produced by the 2009 H1N1 influenza A virus strain.
May 24, 2009 - 4:17:00 AM
|
Latest Research
:
Infectious Diseases
:
AIDS
One step closer to the HIV vaccine
A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine developers.
May 17, 2009 - 11:05:28 AM
|
Latest Research
Humanized mouse infected with HIV vaginally and rectally allows testing
The humanized mouse developed by Dr. J. Victor Garcia-Martinez has allowed the University of Texas Southwestern physician-scientist to conduct HIV/AIDS studies that would have been impossible without such a small animal model of HIV infection. The virus only infects humans and chimpanzees, which are protected as endangered species.
Apr 19, 2009 - 3:59:36 AM
|
Latest Research
:
Infectious Diseases
:
MRSA
New drugs could counter antibiotic resistant hospital infections
Washington, April 9 - Latest research findings that lack of sufficient phosphate in a bacterium could turn it into a killer could help develop new drugs to disarm the antibiotic resistant pathogens that cause serious hospital-acquired infections.
Apr 9, 2009 - 3:59:11 PM
|
Latest Research
Education slowing AIDS in sub-Saharan Africa
Increased schooling across sub-Saharan Africa may be lowering new HIV infections among younger adults, according to sociologists, suggesting a shift in a decades-long trend where formal education is considered an AIDS risk factor.
Mar 22, 2009 - 3:59:36 AM
|
Latest Research
UCSF Transgender HIV Prevention Center funded to provide primary care information
The UCSF Center of Excellence for Transgender HIV Prevention (CoE) has received a grant from The California Endowment that will expand access to information and resources on providing culturally competent health care to trangender individuals.
Mar 12, 2009 - 3:59:36 AM
|
Latest Research
Clinical trial finds microbicide promising as HIV prevention method for women
March 5, 2009 -- A clinical trial involving more than 3,000 women in the U.S. and southern Africa demonstrates for the first time the promise of a vaginal microbicide gel for preventing HIV infection in women. According to findings presented at the Conference on Retroviruses and Opportunistic Infections (CROI), one 0.5 % dose of a microbicide designed to prevent HIV from attaching to cells in the genital tract, was 30% effective. While the results are encouraging, researchers on the study, known as HPTN 035, report that additional evidence is needed to determine more definitively its effectiveness.
Mar 5, 2009 - 4:59:36 AM
|
Latest Research
:
Infectious Diseases
:
AIDS
High rate of HIV treatment interruption among newly released prison inmates
Approximately 80 percent of HIV-infected Texas prison inmates did not fill an initial prescription for antiretroviral therapy within 30 days of their release from prison, potentially increasing their risk for harmful health consequences because of an interruption of treatment, according to a study in the February 25 issue of JAMA.
Feb 25, 2009 - 12:38:05 AM
|
Latest Research
Case Western Reserve University faculty named 2009 NorTech Innovation Award winner
NorTech, in partnership with Crain's Cleveland Business, today presented a 2009 NorTech Innovation Award to Eric J. Arts, Ph.D., for his development of a Biotech Platform to Detect, Monitor, and Treat Viral Diseases. Dr. Arts and his research team developed a set of diagnostic tests used by physicians and researchers to monitor the success of anti-HIV treatment by determining drug resistance and disease strength of the virus. The technology can also be used in academic research to better understand HIV/AIDS and to develop vaccines. Dr. Arts is an Associate Professor of Medicine in the Division of Infectious Diseases, Department of Medicine at Case Western Reserve University School of Medicine. He is also Director of the Uganda Laboratory Core for the Case Western Reserve University Center for Aids Research.
Feb 23, 2009 - 4:59:36 AM
|
Latest Research
:
Infectious Diseases
:
Dengue
New Test to Establish In-Vivo Safety of Dengue Vaccine
Washington, Feb 16 - Researchers have developed a test to determine whether vaccines against a virus that infects 100 million people annually, now ready for clinical trials, should really protect patients from infection, or would make it more dangerous for them.
Feb 16, 2009 - 4:35:46 PM
|
Latest Research
UCSF symposium considers biomedical approaches to HIV/AIDS prevention
New and emerging biomedical approaches to HIV/AIDS prevention will be the focus of a daylong symposium on February 24 sponsored by the UCSF-Gladstone Institute for Virology and Immunology Center for AIDS Research (CFAR) and the UCSF Center for AIDS Prevention Studies.
Feb 12, 2009 - 4:59:36 AM
|
Latest Research
Model of pre-exposure prophylaxis against HIV forecasts benefits, potential cost-effectiveness
WHAT: For every two people who begin treatment for HIV infection globally, five others become newly infected. Therefore, preventing new HIV infections is the foremost strategy for ending the HIV/AIDS epidemic. One potential prevention strategy involves giving antiretroviral drug regimens to people who are at high risk for HIV to protect them from infection. Important questions about this experimental approach, known as pre-exposure prophylaxis (PrEP), remain unanswered, including, Could PrEP cut the lifetime risk of HIV infection? Would PrEP be cost-effective?
Feb 9, 2009 - 4:59:36 AM
|
Latest Research
:
Infectious Diseases
:
AIDS
Breast fed babies on Nevirapine prophylaxis are at risk of developing drug-resistant HIV
Babies born to HIV-positive mothers and given the antiretroviral drug nevirapine through the first six weeks of life to prevent infection via breast-feeding are at high risk for developing drug-resistant HIV if they get infected anyway, a team of researchers report.
Jan 5, 2009 - 11:50:26 AM
|
Latest Research
New book covers full spectrum of neuro-AIDS disorders
In the decade-plus since the introduction of highly active antiretroviral therapy (HAART) for HIV infection, doctors have come to understand that the brain can serve as a reservoir for resistant virus, where it causes a whole different set of symptoms scientists call neuro-AIDS. A new book from ASM Press, The Spectrum of Neuro-AIDS Disorders: Pathophysiology, Diagnosis, and Treatment, presents the full scope of research on the neurological and neurobehavioral implications of HIV/AIDS in a single, unique volume.
Dec 9, 2008 - 4:59:37 AM
|
Latest Research
:
Infectious Diseases
:
Tuberculosis
PA-824 : Promising new drug for TB
An international team of biochemists has discovered how an experimental drug unleashes its destructive force inside the bacteria that cause tuberculosis (TB). The finding could help scientists develop ways to treat dormant TB infections, and suggests a strategy for drug development against other bacteria as well.
Nov 29, 2008 - 3:43:17 AM
|
Latest Research
Individuals with HIV have higher risk of non-AIDS cancers
WASHINGTON, D.C. - The risk of non-AIDS cancer is higher for individuals infected with HIV than for the general population, according to a meta-analysis presented here at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research.
Nov 18, 2008 - 4:59:37 AM
|
Latest Research
:
Infectious Diseases
:
AIDS
Key protein found that helps HIV assault brain
Washington, Nov 15 - Researchers have isolated a key protein that explains why antiviral drugs can fend off the HIV in the body, but not in the brain.
Nov 16, 2008 - 3:26:04 PM
|
Latest Research
:
Infectious Diseases
How household bleach fights bacteria
Despite the fact that household bleach is commonly used as a disinfectant, exactly how it works to fight bacteria remained an open question. Now, a report in the November 14th issue of the journal Cell, a Cell Press publication, provides an answer.
Nov 16, 2008 - 8:36:33 AM
|
Latest Research
:
Infectious Diseases
:
Influenza
Flu shot rates lag for adolescents at risk
Washington, Nov 3 - The rates of flu vaccination for adolescents who suffer from asthma and other illnesses are still far too low, according to a recent study.
Nov 12, 2008 - 2:36:30 PM
|
Latest Research
:
Infectious Diseases
:
MRSA
High-tech system to cut hospital infections by half
London, Nov 6 - Hospital-based infections continue to be the number-two killer in the US after heart disease.
Nov 12, 2008 - 1:58:27 PM
|
Latest Research
:
Infectious Diseases
:
AIDS
Familes fear HIV transmission if parent is infected
Washington, Nov 6 - Two-thirds of families with an HIV-infected parent experienced fears about the virus spreading at home, according to a joint study.
Nov 11, 2008 - 2:47:23 PM
|
Latest Research
:
Infectious Diseases
:
Tuberculosis
Drug resistent TB deadlier, more common than suspected
Washington, Nov 6 - 'Exclusively drug-resistant tuberculosis' or XDR-TB is a menacing public health problem that is even deadlier and more common than suspected.
Nov 11, 2008 - 1:59:29 PM
|
Latest Research
:
Infectious Diseases
:
AIDS
Herpes drug inhibits HIV replication
Washington, Nov 7 - Anti-herpes drug acyclovir can slow down HIV infection by targeting an enzyme, but is also instrumental in the emergence of multi-drug resistant HIV variants.
Nov 11, 2008 - 1:55:19 PM
|
Latest Research
New hope for HIV treatment: Cells exhausted from fighting HIV infection can be revitalized
Researchers at the University of Toronto and the University of California, San Francisco, have revealed new hope for HIV treatment with the discovery of a way to 'rescue' immune cells that are exhausted from fighting off HIV infection.
Nov 10, 2008 - 4:59:37 AM
|
Latest Research
:
Infectious Diseases
Media makes infectious diseases seem much worse
Tornoto, Nov 3 - Popular media coverage of infectious diseases make them seem worse than they are, according to a new Canadian study.
Nov 3, 2008 - 2:57:50 PM
|
Latest Research
:
Infectious Diseases
:
MRSA
MRSA nasal screening not so important
Three Virginia Commonwealth University epidemiologists are downplaying the value of mandatory universal nasal screening of patients for MRSA, arguing that proven, hospital-wide infection control practices can prevent more of the potentially fatal infections.
Oct 23, 2008 - 2:19:21 PM
|
Latest Research
Panel advocates improved understanding of hepatitis B and screening of high-risk populations
Management of hepatitis B is a challenge for physicians and patients due to an incomplete understanding of the disease course, complex treatment indications, and the lack of large studies focusing on important health outcomes. To examine these issues, the NIH convened an independent, impartial panel this week to weigh the available evidence on the management of hepatitis B.
Oct 23, 2008 - 3:59:37 AM
|
Latest Research
Integrating antiretroviral therapy with TB treatment for co-infections reduces mortality
October 16, 2008 -- A South African treatment study conducted by researchers in the Department of Epidemiology at the Mailman School of Public Health shows that mortality among TB-HIV co-infected patients can be reduced by a remarkable 55%, if antiretroviral therapy (ART) is provided with TB treatment at the same time. The randomized, known as the SAPIT (Starting Antiretrovirals at three Points in Tuberculosis) trial, randomly assigned TB-HIV co-infected patients to receive ART. Patients who received ART together with their TB treatment (integrated treatment arm) were compared with patients assigned to receive ART upon completion of TB treatment (sequential treatment arm).
Oct 16, 2008 - 3:59:37 AM
|
|
|
|
|
